Back

Sex-differences in ANOCA patients undergoing invasive coronary function testing: preliminary results from the Dutch national NL-CFT registry

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Diagnosis and treatment of microvascular and epicardial coronary artery disease Nonatherosclerotic Coronary Abnormalities ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Janneke Woudstra

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Simplification of coronary continuous thermodilution
Doctor T. Mahendiran (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
Dysregulation of sympathoadrenal system activity in patients with microvascular angina
Doctor N. Nasirdinov (Andijan, UZ)
Abstract Slides Video
Presentation thumbnail
Prevalence of coronary microvascular disease in myocardial infarction with non-obstructive coronary artery disease
Doctor J. Carrington (Rochester, US) Doctor C. Raphael (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Ticagrelor or prasugrel versus clopidogrel in patients with coronary heart disease
Doctor L. Costa (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Health-related quality of life and long-term incidence of major adverse events in patients with acute coronary syndromes
Mr C. Follonier (Geneva, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Diagnosis and treatment of microvascular and epicardial coronary artery disease
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources